by
Loren Bonner, DOTmed News Online Editor | April 15, 2014
On Monday, GE Healthcare announced that the U.S. Food and Drug Administration has cleared its Revolution CT scanner for market.
The new CT scanner is being marketed for patients who may present more challenges to clinicians, including patients who have high heart rates or metallic implants. Since it can scan patients at a very low dose, it's also well-suited for pediatric patients.
According to GE, the technology is able to address these challenging patients by freezing cardiac motion in one heartbeat, reducing metal artifacts, and offering the potential for sedation-free CT scanning.
Ad Statistics
Times Displayed: 56950
Times Visited: 1656 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"This will be the first CT scanner that's right for physicians in every clinical specialty and provides answers from one CT exam" said Steve Gray, president and CEO of GE Healthcare MICT. "Revolution CT is able to scan even the most challenging patients, day in and day out, with remarkably clear images.
Revolution CT includes a new gantry designed to image at 0.28s rotation speed and tested to support rotation speeds up to 0.2 sec in the future, as well as 16 cm whole organ coverage. The technology has clinical impact for cardiology, oncology and neurology in particular.
